Current research on the immunomodulatory effect of allogeneic blood transfusion

被引:59
作者
Dzik, S
Blajchman, MA
Blumberg, N
Kirkley, SA
Heal, JM
Wood, K
机构
[1] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA
[2] MCMASTER UNIV,DEPT PATHOL,HAMILTON,ON,CANADA
[3] MCMASTER UNIV,DEPT MED,HAMILTON,ON,CANADA
[4] CANADIAN RED CROSS SOC,HAMILTON CTR,HAMILTON,ON,CANADA
[5] UNIV ROCHESTER,DEPT PATHOL & LAB MED,TRANSFUS MED UNIT,ROCHESTER,NY
[6] UNIV ROCHESTER,DEPT PATHOL & LAB MED,HEMATOL UNIT,ROCHESTER,NY
[7] UNIV ROCHESTER,DEPT MED,ROCHESTER,NY
[8] AMER RED CROSS,BLOOD SERV,NEW YORK PENN REG,ROCHESTER,NY
[9] UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT SURG,OXFORD OX3 9DU,ENGLAND
关键词
D O I
10.1111/j.1423-0410.1996.tb01324.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review summarizes three aspects of current research on the immunomodulatory effect of allogeneic transfusion, Representatives of three laboratories each of which is actively engaged in research on transfusion-induced immunomodulation - summarize their current investigative approach, First, current animal models of transfusion-induced immunomodulation are presented and research on the tumor growth-promoting effect of allogeneic transfusion is described. Second, mechanisms underlying an immunomodulatory effect of transfusion are summarized and experiments on the induction of transplant tolerance by selective introduction of donor-type MHC antigens is presented. Third, - the potential clinical impact of increased infection and tumor recurrence resulting from transfusion-induced immunomodulation is assessed. The potential role of donor-derived hematopoietic stem cells is presented as an area of future investigation in the area of transfusion-induced immunomodulation.
引用
收藏
页码:187 / 194
页数:8
相关论文
共 56 条
[1]  
ADAMS PT, 1992, BLOOD, V80, P551
[2]  
BELL Y, 1993, TRANSPLANT P, V25, P359
[3]   INDUCTION OF TOLERANCE BY MONOCLONAL-ANTIBODY THERAPY [J].
BENJAMIN, RJ ;
WALDMANN, H .
NATURE, 1986, 320 (6061) :449-451
[4]   ACTIVELY ACQUIRED TOLERANCE OF FOREIGN CELLS [J].
BILLINGHAM, RE ;
BRENT, L ;
MEDAWAR, PB .
NATURE, 1953, 172 (4379) :603-606
[5]  
Blajchman M A, 1994, Curr Opin Hematol, V1, P457
[6]  
BLAJCHMAN MA, 1993, BLOOD, V81, P1880
[7]   THE TUMOR GROWTH-PROMOTING EFFECT OF ALLOGENEIC BLOOD-TRANSFUSIONS [J].
BLAJCHMAN, MA ;
BORDIN, JO .
IMMUNOLOGICAL INVESTIGATIONS, 1995, 24 (1-2) :311-317
[8]   FURTHER EVIDENCE SUPPORTING A CAUSE AND EFFECT RELATIONSHIP BETWEEN BLOOD-TRANSFUSION AND EARLIER CANCER RECURRENCE [J].
BLUMBERG, N ;
HEAL, J ;
CHUANG, C ;
MURPHY, P ;
AGARWAL, M .
ANNALS OF SURGERY, 1988, 207 (04) :410-415
[9]  
BORDIN JO, 1994, BLOOD, V84, P344
[10]   BLOCKADE OF THE CD28 COSTIMULATORY PATHWAY - A MEANS TO INDUCE TOLERANCE [J].
BOUSSIOTIS, VA ;
GRIBBEN, JG ;
FREEMAN, GJ ;
NADLER, LM .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (05) :797-807